8-(Phenylamino)-1-(propan-2-yl)-4,5-dihydro-1H-pyrazolo[4,3-h]-quinazoline-3-carboxamide

ID: ALA1094735

PubChem CID: 46223566

Max Phase: Preclinical

Molecular Formula: C19H20N6O

Molecular Weight: 348.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)n1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2

Standard InChI:  InChI=1S/C19H20N6O/c1-11(2)25-17-14(16(24-25)18(20)26)9-8-12-10-21-19(23-15(12)17)22-13-6-4-3-5-7-13/h3-7,10-11H,8-9H2,1-2H3,(H2,20,26)(H,21,22,23)

Standard InChI Key:  OQCYIOKKFGCDSR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   18.0069   -2.1333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0057   -2.9607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7206   -3.3735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7188   -1.7205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4341   -2.1297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4375   -2.9581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8658   -2.1238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1460   -1.7102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8692   -2.9523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1517   -3.3684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3257   -4.1794    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1508   -4.2645    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4866   -3.5061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1958   -3.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9142   -3.4931    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.1879   -2.2625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2909   -3.3726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5768   -2.9595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5779   -2.1347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8646   -1.7217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1488   -2.1337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1508   -2.9629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8647   -3.3722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9083   -4.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0834   -4.8864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3162   -5.6088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
  3  6  2  0
 13 14  1  0
  1  2  2  0
 14 15  1  0
  5  8  1  0
 14 16  2  0
  6 10  1  0
  2 17  1  0
  9  7  1  0
 17 18  1  0
  7  8  1  0
 18 19  2  0
  9 10  2  0
 19 20  1  0
  5  4  2  0
 20 21  2  0
  4  1  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 23 18  1  0
 11 24  1  0
  2  3  1  0
 24 25  1  0
 10 11  1  0
 24 26  1  0
M  END

Associated Targets(Human)

CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 348.41Molecular Weight (Monoisotopic): 348.1699AlogP: 2.86#Rotatable Bonds: 4
Polar Surface Area: 98.72Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.40CX Basic pKa: 1.71CX LogP: 3.12CX LogD: 3.12
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -1.19

References

1. Beria I, Ballinari D, Bertrand JA, Borghi D, Bossi RT, Brasca MG, Cappella P, Caruso M, Ceccarelli W, Ciavolella A, Cristiani C, Croci V, De Ponti A, Fachin G, Ferguson RD, Lansen J, Moll JK, Pesenti E, Posteri H, Perego R, Rocchetti M, Storici P, Volpi D, Valsasina B..  (2010)  Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors.,  53  (9): [PMID:20397705] [10.1021/jm901713n]

Source